4//SEC Filing
Aviragen Therapeutics, Inc. 4
Accession 0001437749-17-006117
$VXRTCIK 0000072444operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 1:09 PM ET
Size
5.4 KB
Accession
0001437749-17-006117
Insider Transaction Report
Form 4
PATTI JOSEPH M
EVP, Corporate Dev & Strategy
Transactions
- Award
Stock Option (Right to Buy)
2017-04-03$0.66/sh+650,000$426,400→ 2,113,304 totalExercise: $0.66From: 2017-10-03Exp: 2027-04-03→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]This stock option vests as follows: 33% of the total stock option vests six (6) months after the grant date, on October 3, 2017 and the remainder of the stock option vests in equal monthly installments beginning November 3, 2017 to April 3, 2018.
Documents
Issuer
Aviragen Therapeutics, Inc.
CIK 0000072444
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000072444
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 1:09 PM ET
- Size
- 5.4 KB